Effects of Bone Graft Placement at Implant Installation on Buccal Plate Stability
Withdrawn before enrolling · Not applicable
Conditions studied: Peri-implant Alveolar Bone Thickness
In brief
This randomized clinical trial will involve at least 25 patients who have selected to receive a dental implant to replace a missing tooth. One group will receive the test treatment of a bone graft and a dissolvable membrane at the outer surface of the dental, while the control group will not receive the bone graft and membrane adjacent to the implant. The following will be measured: bone thickness and height adjacent to implant, inflammation of gum tissue, recession of gum tissue, bleeding, pocket depth, and implant success. Patients will be followed for 1 year, including evaluation time points at 2 weeks, 1 month, 3 and 6 months, and 1 year. Statistical analysis of the data will be conducted. The hypothesis is that there is no difference with regard to bone thickness, bone height, pocket depth, bleeding, and implant success rate for grafted implant sites compared to non-grafted implant sites.
Key facts
- Study ID
- NCT01245920
- Run by
- Creighton University
- People needed
- 0
- Starts
- 2010-11-01
- Expected to finish
- 2012-05-01
- Last updated by the study team
- 2012-08-30
Who can join
Age: 21 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Subjects willing and able to follow study procedures.
- Subjects treatment plan includes the placement of at least one endosseous dental implant in the maxillary or mandibular arch.
- Subjects must present with at least 1 mm buccal bone thickness immediately after surgical placement of endosseous dental implant.
- Subjects must demonstrate a plaque index of ≤20%.
- Subjects who can read, understand, and sign an institutional review board approved informed consent.
You may not qualify if…
- Subjects with systemic condition including diabetes mellitus, cancer, human immunodeficiency virus, or bone metabolic disease.
- Subjects who take corticosteroids, immunosuppressant, bisphosphonates, radiation treatments, and/or chemotherapeutics that could compromise wound healing process.
- Subjects with acute infectious lesions in the area of study.
- Subjects under 21 years of age.
- Subjects with previous failed endosseous dental implant at the site of study.
- Smokers.
- Subjects with dehiscence of implant surface > 1 mm immediately after surgical placement of endosseous dental implant.
Where it is running
- Creighton University School of Dentistry — Omaha, Nebraska, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.